Key facts
- This page summarizes Dan Puckett's Form 4 filing for Shockwave Medical, Inc..
- 6 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Feb 2024, 20:10.
Dan Puckett - 05 Feb 2024 Form 4 Insider Report for Shockwave Medical, Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 05 Feb 2024
- Net transaction value
- -$1,537,962
- SEC form
- 4
- Accepted by SEC
- 06 Feb 2024, 20:10:18 UTC
- Prior SEC filing
- 02 Feb 2024
- Next SEC filing
- 09 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wade Estey, as attorney-in-fact for Dan Puckett
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dan Puckett filed Form 4 for Shockwave Medical, Inc. on 06 Feb 2024.
Change
- Previous filing in this sequence was filed on 02 Feb 2024.
- Current net transaction value: -$1,537,962.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SWAV
transaction
Common Stock
Tax liability
- Transaction value
- $499,648
- Shares
- -2,208
- Change %
- -8%
- Price
- $226.29
- Shares after
- 25,524
- Date
- 05 Feb 2024
- Ownership
- Direct
SWAV
transaction
Common Stock
Tax liability
- Transaction value
- $243,714
- Shares
- -1,077
- Change %
- -4.2%
- Price
- $226.29
- Shares after
- 24,447
- Date
- 05 Feb 2024
- Ownership
- Direct
SWAV
transaction
Common Stock
Tax liability
- Transaction value
- $48,206
- Shares
- -213
- Change %
- -0.87%
- Price
- $226.32
- Shares after
- 24,234
- Date
- 05 Feb 2024
- Ownership
- Direct
SWAV
transaction
Common Stock
Sale
- Transaction value
- $68,781
- Shares
- -300
- Change %
- -1.2%
- Price
- $229.27
- Shares after
- 23,934
- Date
- 05 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
SWAV
transaction
Common Stock
Sale
- Transaction value
- $393,376
- Shares
- -1,703
- Change %
- -7.1%
- Price
- $230.99
- Shares after
- 22,231
- Date
- 05 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F3
SWAV
transaction
Common Stock
Sale
- Transaction value
- $284,236
- Shares
- -1,226
- Change %
- -5.5%
- Price
- $231.84
- Shares after
- 21,005
- Date
- 05 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Dan Puckett is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023.
Footnote F2
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Footnote F3
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Footnote F4
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.